GelVac Nasal Powder H5N1 Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GelVac Nasal Powder H5N1 Influenza Vaccine, covering 2017-02-02 to 2017-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults [Phase 1]